Cardiovascular Problems with Lexiva (February 2010)

GlaxoSmithKline is notifying healthcare professionals that Lexiva (fosamprenavir calcium), a protease inhibitor, has been associated with an increased risk of myocardial infarction and dyslipidemia in HIV infected adults. The company’s letter recommends that patients have their cholesterol and triglycerides tested prior to starting therapy with Lexiva and at periodic intervals during treatment with the drug. […]

LifeSource? “February is Heart Month” Promotion

Montreal, Quebec (PRWEB) January 17, 2007 After a very successful initial promotion in 2006, which resulted in a donation of over ,000, Auto Control Medical’s LifeSource blood pressure monitor brand is once again teaming with the Heart and Stroke Foundation of Canada to encourage Canadians who have or are at risk of developing hypertension to […]